All In MedTech

FDA Clearance Tracker · P980046

HOME ACCESS HEPATITIS C CHECK AND HEPATITIS C CHECK EXPRESS

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Apr 28, 1999 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Apr 28, 1999

Approved

Time to decision

142 days

Received Dec 7, 1998. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P980046
Device name
HOME ACCESS HEPATITIS C CHECK AND HEPATITIS C CHECK EXPRESS
Applicant location
New York, NY
Received
Dec 7, 1998
Decided
Apr 28, 1999
Decision
Approved
Expedited review
Yes, flagged as expedited in FDA's record.
Supplements
7 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code QRO

FDA's approval statement

As written in FDA's record.

Approval for the Home Access(R) Hepatitis C Check(SM) and Hepatitis C Check(SM) Express. This device is indicated for home use for collection of a dried blood spot speciment by finger-stick, and is indicated for anonymous testing for antibody to hepatitis C virus (HCV) in adults, eighteen years or older, who may have been exposed to HCV through transfusion or organ transplant before 1992, who may have injected non-prescription durgs, or who were exposed to infected needles or had sexual contacts with HCV infected individuals.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code QRO (Immunoassay for the detection of antibody to Hepatitis C Virus intended for over the counter use).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Pwn Health Chicago, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.